AmerisourceBergen is the second-largest distributor of pharmaceuticals in the U.S. As such, it’s subject to many of the same forces affecting McKesson, its top competitor. Branded drug price deflation and fewer expected new drug launches continue to put pressure on industry profits, and AmerisourceBergen has been working to counter those effects. The company was founded in 1985 and is headquartered in Chesterbrook, Penn.
Looking for leads, investment insights, or competitive intelligence?
News about AmerisourceBergen
Corporate governance matters, too.
New report highlights revolving door between DEA and industry.
The company is facing lawsuits from devastated communities in West Virginia.
And the lawmakers who called for the probe now want it expanded to diabetes drugs.
But health care stocks are hot.